MethaCholine Bronchoprovocation Study (MeCIS)
clinical trial
Press Enter · cited answer in seconds
0 sources
MethaCholine Bronchoprovocation Study (MeCIS)
Summary
MethaCholine Bronchoprovocation Study (MeCIS) is a clinical trial[1].
Key Facts
- MethaCholine Bronchoprovocation Study (MeCIS) is in the country of United States[2].
- MethaCholine Bronchoprovocation Study (MeCIS)'s instance of is recorded as clinical trial[3].
- MethaCholine Bronchoprovocation Study (MeCIS)'s start time is recorded as +2009-01-31T00:00:00Z[4].
- MethaCholine Bronchoprovocation Study (MeCIS)'s end time is recorded as +2010-02-28T00:00:00Z[5].
- MethaCholine Bronchoprovocation Study (MeCIS)'s contributor to the creative work or subject is recorded as Long Island Jewish Medical Center[6].
- MethaCholine Bronchoprovocation Study (MeCIS)'s contributor to the creative work or subject is recorded as North Shore University Hospital[7].
- MethaCholine Bronchoprovocation Study (MeCIS)'s contributor to the creative work or subject is recorded as University of Florida[8].
- MethaCholine Bronchoprovocation Study (MeCIS)'s contributor to the creative work or subject is recorded as Grossman School of Medicine[9].
- MethaCholine Bronchoprovocation Study (MeCIS)'s contributor to the creative work or subject is recorded as Northwestern University[10].
- MethaCholine Bronchoprovocation Study (MeCIS)'s contributor to the creative work or subject is recorded as University of California, San Diego[11].
- MethaCholine Bronchoprovocation Study (MeCIS)'s main subject is recorded as asthma[12].
- MethaCholine Bronchoprovocation Study (MeCIS)'s number of participants is recorded as {'unit': '1', 'amount': '+219'}[13].
- MethaCholine Bronchoprovocation Study (MeCIS)'s title is recorded as MethaCholine Bronchoprovocation - Influence of High Potency Inhaled corticoSteroids in Asthma (MeCIS) Study[14].
- MethaCholine Bronchoprovocation Study (MeCIS)'s short name is recorded as MeCIS[15].
- MethaCholine Bronchoprovocation Study (MeCIS)'s minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+12'}[16].
- MethaCholine Bronchoprovocation Study (MeCIS)'s ClinicalTrials.gov ID is recorded as NCT00705341[17].
- MethaCholine Bronchoprovocation Study (MeCIS)'s maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+69'}[18].
- MethaCholine Bronchoprovocation Study (MeCIS)'s research intervention is recorded as methacholine chloride[19].
- MethaCholine Bronchoprovocation Study (MeCIS)'s clinical trial phase is recorded as phase IV clinical trial[20].
- MethaCholine Bronchoprovocation Study (MeCIS)'s research site is recorded as Indiana University – Purdue University Indianapolis[21].
- MethaCholine Bronchoprovocation Study (MeCIS)'s research site is recorded as Washington University School of Medicine[22].
- MethaCholine Bronchoprovocation Study (MeCIS)'s research site is recorded as New York Medical College[23].
- MethaCholine Bronchoprovocation Study (MeCIS)'s research site is recorded as Ohio State University[24].
- MethaCholine Bronchoprovocation Study (MeCIS)'s research site is recorded as Long Island Jewish Medical Center[25].
- MethaCholine Bronchoprovocation Study (MeCIS)'s study type is recorded as interventional study[26].